Literature DB >> 21425043

Risk of high-grade dysplasia or carcinoma in gastric biopsy-proven low-grade dysplasia: an analysis using the Vienna classification.

S-J Cho1, I J Choi, C G Kim, J Y Lee, M-C Kook, S Park, K W Ryu, J H Lee, Y-W Kim.   

Abstract

BACKGROUND AND AIMS: Therapeutic guidelines have not yet been established for low-grade gastric adenomas/dysplasias (LGD), which have a low risk of progression to high-grade adenomas/dysplasias (HGD) or to invasive carcinomas. This study aimed to evaluate risk factors for HGD/carcinoma that indicate a need for resection in biopsy-proven LGD lesions. PATIENTS AND METHODS: In total, 236 LGD lesions from 208 consecutive patients treated with endoscopic resection (ER) were retrospectively studied between 2004 and 2008. The Vienna classification was used for histological diagnosis. A generalized estimating equation (GEE) logistic regression model was used for multivariate analysis.
RESULTS: Among the 236 LGD lesions, the final pathology diagnosed 9 (3.8 %) as invasive carcinoma (category 5), 71 (30.1 %) as HGD (category 4), 148 (62.7 %) as LGD (category 3), and 8 (3.4 %) as negative/indefinite for dysplasia (category 1/2). Lesions ≥ 1 cm were classified as HGD/carcinoma in 39.4 % of patients (65/165). Multivariate analysis indicated that size of ≥ 1 cm (OR 1.93 [95 % CI, 1.06 - 3.52]), depressed morphology (OR 3.81 [95 % CI, 1.22 - 11.9]), and erythema (OR 2.49 [95 % CI, 1.31 - 4.72]) were significantly associated with HGD/carcinoma. The OR increased to 47.6 (95 % CI, 4.27 - 530.65) when the risk factors were all positive. The sensitivity and negative predictive value for ≥ 1 risk factors were 93.8 % and 90.9 %, respectively. As the number of risk factors of a lesion increased, the specificity and positive predictive value also increased.
CONCLUSIONS: Endoscopic resection can be recommended if a low-grade dysplastic lesion has at least one of the following risk factors: depressed morphology, surface erythema, or a size of 1 cm or greater. For lesions that have none of the three risk factors, follow-up endoscopy is recommended. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2011        PMID: 21425043     DOI: 10.1055/s-0030-1256236

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  39 in total

1.  Endoscopic submucosal dissection for gastric indefinite for neoplasia: which lesions should be resected?

Authors:  Hyeong Seok Nam; Cheol Woong Choi; Su Jin Kim; Dae Hwan Kang; Hyung Wook Kim; Su Bum Park; Dae Gon Ryu
Journal:  Surg Endosc       Date:  2019-02-25       Impact factor: 4.584

2.  Gastric adenoma with low-grade dysplasia: two countries, two outcomes.

Authors:  Sun-Young Lee
Journal:  Dig Dis Sci       Date:  2013-09-20       Impact factor: 3.199

Review 3.  Optimal management of biopsy-proven low-grade gastric dysplasia.

Authors:  Jung-Wook Kim; Jae Young Jang
Journal:  World J Gastrointest Endosc       Date:  2015-04-16

4.  Endoscopic predictors for undifferentiated histology in differentiated gastric neoplasms prior to endoscopic resection.

Authors:  Ji Min Choi; Sang Gyun Kim; Hyo-Joon Yang; Joo Hyun Lim; Jeongmin Choi; Jong Pil Im; Joo Sung Kim; Woo Ho Kim; Hyun Chae Jung
Journal:  Surg Endosc       Date:  2015-03-27       Impact factor: 4.584

5.  Clinical features of negative pathologic results after gastric endoscopic submucosal dissection.

Authors:  Dong Il Jeong; Hyung Wook Kim; Cheol Woong Choi; Dae Hwan Kang; Su Bum Park; Su Jin Kim; Hyeong Seok Nam
Journal:  Surg Endosc       Date:  2016-07-12       Impact factor: 4.584

6.  Methylation-dependent activation of CDX1 through NF-κB: a link from inflammation to intestinal metaplasia in the human stomach.

Authors:  Tilman T Rau; Anja Rogler; Myrjam Frischauf; Andreas Jung; Peter C Konturek; Arno Dimmler; Gerhard Faller; Bettina Sehnert; Wael El-Rifai; Arndt Hartmann; Reinhard E Voll; Regine Schneider-Stock
Journal:  Am J Pathol       Date:  2012-06-27       Impact factor: 4.307

7.  Risk factors associated with diagnostic discrepancy of gastric indefinite neoplasia: Who need en bloc resection?

Authors:  Ja Jun Goo; Cheol Woong Choi; Dae Hwan Kang; Hyung Wook Kim; Su Bum Park; Mong Cho; Sun Hwi Hwang; Si Hak Lee
Journal:  Surg Endosc       Date:  2015-04-17       Impact factor: 4.584

8.  Predictors of upstage diagnosis after endoscopic resection of gastric low-grade dysplasia.

Authors:  Dae Hwan Kang; Cheol Woong Choi; Hyung Wook Kim; Su Bum Park; Su Jin Kim; Hyeong Seok Nam; Dae Gon Ryu
Journal:  Surg Endosc       Date:  2017-12-06       Impact factor: 4.584

9.  Argon plasma coagulation is safe and effective for treating smaller gastric lesions with low-grade dysplasia: a comparison with endoscopic submucosal dissection.

Authors:  Se Jin Jung; Soo-Jeong Cho; Il Ju Choi; Myeong-Cherl Kook; Chan Gyoo Kim; Jong Yeul Lee; Sook Ryun Park; Jun Ho Lee; Keun Won Ryu; Young-Woo Kim
Journal:  Surg Endosc       Date:  2012-10-18       Impact factor: 4.584

10.  The risk factors for discrepancy after endoscopic submucosal dissection of gastric category 3 lesion (low grade dysplasia).

Authors:  Cheol Woong Choi; Hyung Wook Kim; Dong Hoon Shin; Dae Hwan Kang; Yong Mi Hong; Jin Hyun Park; Su Bum Park; Mong Cho; Jung Hee Lee
Journal:  Dig Dis Sci       Date:  2013-12-24       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.